Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹3,265 Cr
P/E Ratio
24.56
P/B Ratio
2.37
Industry P/E
39.48
Debt to Equity
0.02
ROE
10.72 %
ROCE
14.78 %
Div. Yield
1.75 %
Book Value
123.39
EPS
12.85
CFO
₹1,206.92 Cr
EBITDA
₹1,726.77 Cr
Net Profit
₹1,079.92 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Advanced Enzyme
| -16.18 | 9.36 | -15.10 | -18.83 | -2.44 | 11.97 | -- |
|
BSE Commodities
| 1.36 | 5.01 | 3.59 | 5.09 | 6.48 | 28.17 | -- |
|
BSE Small Cap
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Advanced Enzyme
| -6.85 | 33.67 | -13.89 | -3.15 | 103.50 | -5.86 | -36.52 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Commodities
| 8.14 | 17.51 | 1.22 | 61.53 | 26.07 | -4.62 | -19.21 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 827.80 | 10,987.75 | 102.98 | -- | |
| 802.70 | 8,903.89 | 111.74 | 2.87 | |
| 10,143.60 | 8,041.52 | 57.62 | 17.46 | |
| 660.05 | 10,550.78 | 51.13 | 7.43 |
No Review & Analysis are available.
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers... enzymes and probiotics-based nutritional supplements for human healthcare and animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India. Read more
Incorporated
1989
Chairman
Vasant Rathi
Managing Director
--
Headquarters
Thane, Maharashtra
Website
Looking for more details about Advanced Enzyme Technologies Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Advanced Enzyme Technologies Ltd stood at ₹ 1,549 Cr as on 31-Dec-24
The share price of Advanced Enzyme Technologies Ltd is ₹292.00 (NSE) and ₹291.85 (BSE) as of 17-Apr-2025 IST. Advanced Enzyme Technologies Ltd has given a return of -2.44% in the last 3 years.
Advanced Enzyme Technologies Ltd has a market capitalisation of ₹ 3,265 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Advanced Enzyme Technologies Ltd is 2.37 times as on 17-Apr-2025, a 26% discount to its peers’ median range of 3.21 times.
The P/E ratio of Advanced Enzyme Technologies Ltd is 24.56 times as on 17-Apr-2025, a 38% discount to its peers’ median range of 39.48 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Advanced Enzyme Technologies Ltd and enter the required number of quantities and click on buy to purchase the shares of Advanced Enzyme Technologies Ltd.
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.
The promoters of Advanced Enzyme Technologies Ltd are Vasant Rathi and Rasika Vasant Rathi. They collectively own 35.41 per cent of the total equity. The chairman of the company is Vasant Rathi
There is no promoter pledging in Advanced Enzyme Technologies Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,988
|
|
|
10,551
|
|
|
8,904
|
|
|
8,042
|
| Advanced Enzyme Technologies Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
10.79
|
|
Operating margin(%)
|
26.84
|
|
Net Margin(%)
|
20.73
|
|
Dividend yield(%)
|
1.75
|
Yes, TTM profit after tax of Advanced Enzyme Technologies Ltd was ₹133 Cr.
₹1.85
(
